Rankings
▼
Calendar
IRD Q1 2025 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena
IRD
Opus Genetics, Inc.
$349M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+155.4% YoY
Gross Profit
$4M
100.0% margin
Operating Income
-$10M
-227.2% margin
Net Income
-$8M
-187.5% margin
EPS (Diluted)
$-0.24
QoQ Revenue Growth
+1.6%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$913,000
Balance Sheet
Total Assets
$48M
Total Liabilities
$43M
Stockholders' Equity
$5M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$2M
+155.4%
Gross Profit
$4M
$2M
+155.4%
Operating Income
-$10M
-$8M
-28.8%
Net Income
-$8M
-$7M
-15.3%
← Q4 2024
All Quarters
Q2 2025 →